kynurenine and minocycline

kynurenine has been researched along with minocycline in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	3 (75.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
André, C; Castanon, N; Dantzer, R; Kelley, KW; Lawson, MA; Lestage, J; Moreau, M; O'Connor, JC	1
Anderson, C; Clifford, D; Cohen, B; Drewes, JL; Evans, S; Graham, D; Haughey, N; Hosey, L; McCarthy, S; Miyahara, S; Nath, A; Pardo, CA; Sacktor, N; Schifitto, G; Zink, MC	1
Brandão, ML; Carabelli, B; Cunha, JM; Cunha, TM; da Silva Dias, IC; de Carvalho, MC; de Morais, H; Ferraz, AC; Ishii, DK; Rizzo de Souza, LE; Zanata, SM; Zanoveli, JM	1
Boeira, SP; de Gomes, MG; Jesse, CR; Mattos, E; Silva, NC; Souza, LC; Viana, CE	1

Trials

1 trial(s) available for kynurenine and minocycline

Article	Year
Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment. Journal of neurovirology, 2014, Volume: 20, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Ceramides; Cytokines; Double-Blind Method; Female; Glutamic Acid; HIV-1; Humans; Kynurenine; Male; Middle Aged; Minocycline; Neurofilament Proteins; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress	2014

Article

Year

Impact of minocycline on cerebrospinal fluid markers of oxidative stress, neuronal injury, and inflammation in HIV-seropositive individuals with cognitive impairment.

Journal of neurovirology, 2014, Volume: 20, Issue:6

Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; AIDS Dementia Complex; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Ceramides; Cytokines; Double-Blind Method; Female; Glutamic Acid; HIV-1; Humans; Kynurenine; Male; Middle Aged; Minocycline; Neurofilament Proteins; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type II; Oxidative Stress

2014

Other Studies

3 other study(ies) available for kynurenine and minocycline

Article	Year
Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular psychiatry, 2009, Volume: 14, Issue:5 Topics: Animals; Behavior, Animal; Chromatography, High Pressure Liquid; Cytokinins; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Hindlimb Suspension; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Minocycline; Motor Activity; Swimming; Time Factors; Tryptophan	2009
Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes. Molecular neurobiology, 2016, Volume: 53, Issue:10 Topics: Animals; Antidepressive Agents; Behavior, Animal; Blood Glucose; Cytokines; Depression; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Fluoxetine; Hippocampus; Ibuprofen; Indoleamine-Pyrrole 2,3,-Dioxygenase; Inflammation Mediators; Kynurenine; Male; Minocycline; Molecular Targeted Therapy; Motor Activity; Norepinephrine; Rats, Wistar; Serotonin; Swimming; Tryptophan; Weight Gain	2016
Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase. Neurotoxicity research, 2017, Volume: 31, Issue:4 Topics: Animals; Blood Glucose; Cytokines; Depression; Disease Models, Animal; Grooming; Hippocampus; Hydroxyindoleacetic Acid; Immobility Response, Tonic; Indoleamine-Pyrrole 2,3,-Dioxygenase; Infusions, Intraventricular; Kynurenine; Male; Mice; Minocycline; Serotonin; Streptozocin; Tryptophan	2017